Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Journal of Glaucoma
|
June 16, 2009
The relationship of mean deviation scores and resource utilization among patients with glaucoma: a retrospective United States and European chart review analysis
Karina Berenson, Steven Kymes, John G Walt, et al.
International Journal of Methods in Psychiatric Research
|
April 9, 2019
Identifying and characterizing treatment-resistant schizophrenia in observational database studies
Linus Jönsson, Jacob Simonsen, Cecilia Brain, et al.
The Journal of Headache and Pain
|
September 21, 2022
Development and validation of a novel model for characterizing migraine outcomes within real-world data
Nada A Hindiyeh, Daniel Riskin, Kimberly Alexander, et al.
Ophthalmology
|
April 17, 2012
Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
Vinay Dewan, Dennis Lambert, Joshua Edler, et al.
BMC Psychiatry
|
August 15, 2018
Experiences, attitudes, and perceptions of caregivers of individuals with treatment-resistant schizophrenia: a qualitative study
Cecilia Brain, Steven Kymes, Dana B DiBenedetti, et al.
Journal of Medical Economics
|
January 31, 2019
A systematic literature review identifying associations between outcomes and quality of life (QoL) or healthcare resource utilization (HCRU) in schizophrenia
Nicola Germain, Steven Kymes, Elin Löf, et al.
Journal of Racial and Ethnic Health Disparities
|
August 6, 2025
Migraine-Related Burden, Treatment Interventions, and Healthcare Experiences by Race and Ethnicity: Results of the Migraine Report Card Survey
Amaal J Starling, Dawn C Buse, Roger Cady, et al.
BMC Neurology
|
April 20, 2023
Early clinical experience with eptinezumab: results of a retrospective observational study of patient response in the United States
Amaal J Starling, Steven Kymes, Divya Asher, et al.
BMC Medical Informatics and Decision Making
|
July 14, 2023
Using artificial intelligence to identify patients with migraine and associated symptoms and conditions within electronic health records
Daniel Riskin, Roger Cady, Anand Shroff, et al.
Journal of Market Access & Health Policy
|
January 17, 2022
Psychometric validation of a patient-reported single-item assessment of 'Good Day Bad Day' in a neurogenic orthostatic hypotension population treated with droxidopa
Clément François, Nicola Germain, Renata Majewska, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Journal of Glaucoma
|
June 16, 2009
The relationship of mean deviation scores and resource utilization among patients with glaucoma: a retrospective United States and European chart review analysis
Karina Berenson, Steven Kymes, John G Walt, et al.
International Journal of Methods in Psychiatric Research
|
April 9, 2019
Identifying and characterizing treatment-resistant schizophrenia in observational database studies
Linus Jönsson, Jacob Simonsen, Cecilia Brain, et al.
The Journal of Headache and Pain
|
September 21, 2022
Development and validation of a novel model for characterizing migraine outcomes within real-world data
Nada A Hindiyeh, Daniel Riskin, Kimberly Alexander, et al.
Ophthalmology
|
April 17, 2012
Cost-effectiveness analysis of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
Vinay Dewan, Dennis Lambert, Joshua Edler, et al.
BMC Psychiatry
|
August 15, 2018
Experiences, attitudes, and perceptions of caregivers of individuals with treatment-resistant schizophrenia: a qualitative study
Cecilia Brain, Steven Kymes, Dana B DiBenedetti, et al.
Journal of Medical Economics
|
January 31, 2019
A systematic literature review identifying associations between outcomes and quality of life (QoL) or healthcare resource utilization (HCRU) in schizophrenia
Nicola Germain, Steven Kymes, Elin Löf, et al.
Journal of Racial and Ethnic Health Disparities
|
August 6, 2025
Migraine-Related Burden, Treatment Interventions, and Healthcare Experiences by Race and Ethnicity: Results of the Migraine Report Card Survey
Amaal J Starling, Dawn C Buse, Roger Cady, et al.
BMC Neurology
|
April 20, 2023
Early clinical experience with eptinezumab: results of a retrospective observational study of patient response in the United States
Amaal J Starling, Steven Kymes, Divya Asher, et al.
BMC Medical Informatics and Decision Making
|
July 14, 2023
Using artificial intelligence to identify patients with migraine and associated symptoms and conditions within electronic health records
Daniel Riskin, Roger Cady, Anand Shroff, et al.
Journal of Market Access & Health Policy
|
January 17, 2022
Psychometric validation of a patient-reported single-item assessment of 'Good Day Bad Day' in a neurogenic orthostatic hypotension population treated with droxidopa
Clément François, Nicola Germain, Renata Majewska, et al.
Page
of 4